Tolerability/safety of sunitinib (SU) on schedule 2/1 in combination with capecitabine (C) in patients (pts) with advanced solid tumors (STs): A phase I dose-finding study

被引：1
|
作者：
Chiorean, E. G.
Sweeney, C. J.
Verschraegen, C. F.
Lee, F. C.
Jones, S. F.
Rabinowitz, I.
Tye, L.
Bello, A.
Chao, R.
Burris, H. A., III
机构：
[1] Univ New Mexico, Albuquerque, NM 87131 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
[3] Sarah Cannon Res Inst, Nashville, TN USA
[4] Pfizer Global Res & Dev, La Jolla, CA USA
[5] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.3562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3562
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A phase I dose-finding study of sunitinib (SU) in combination with gemcitabine (G) in patients (pts) with advanced solid tumors
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] A PHASE I DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH GEMCITABINE (G) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
    Michaelson, M. D.
    Schwarzberg, A.
    Ryan, D.
    McDermott, D.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Selaru, P.
    Wang, E.
    Zhu, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 156
  • [3] Phase I tolerability/safety of sunitinib in combination with capecitabine in patients (pts) with advanced solid tumors
    Verschraegen, C.
    Sweeney, C.
    Chiorean, G.
    Lee, F. C.
    Jones, S.
    Tye, L.
    Bello, A.
    Chao, R.
    Burris, H., III
    EJC SUPPLEMENTS, 2007, 5 (04): : 111 - 111
  • [4] PHASE I, DOSE-FINDING STUDY OF SUNITINIB (SU) IN COMBINATION WITH IRINOTECAN (IR) IN PATIENTS WITH ADVANCED SOLID TUMOURS
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Contouriotis, A. M.
    Law, C. N. J.
    Soria, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 156 - 157
  • [5] Phase I dose-finding study of trabectedin (T) in combination with cisplatin (C) in patients (pts) with advanced solid tumors.
    Sessa, C.
    Gallerani, E.
    Del Conte, G.
    Christinat, A.
    Perotti, A.
    Lardelli, P.
    Kahatt, C. M.
    Florez, A.
    Fernandez, C.
    Miani, M.
    Gianni, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    Boven, E.
    Massard, C.
    Armand, J. P.
    Tillier, C.
    Hartog, V.
    Brega, N. M.
    Countouriotis, A. M.
    Ruiz-Garcia, A.
    Soria, J. C.
    BRITISH JOURNAL OF CANCER, 2010, 103 (07) : 993 - 1000
  • [7] A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
    E Boven
    C Massard
    J P Armand
    C Tillier
    V Hartog
    N M Brega
    A M Countouriotis
    A Ruiz-Garcia
    J C Soria
    British Journal of Cancer, 2010, 103 : 993 - 1000
  • [8] Phase I safety and pharmacokinetic (PK) study of sunitinib (S) in combination with ifosfamide (I) in patients (pts) with advanced solid tumors (STs)
    Hamberg, P.
    Steeghs, N.
    Loos, W. J.
    van der Biessen, D. J.
    den Hollander, M. A.
    Tascilar, M.
    Verweij, J.
    Gelderblom, H.
    Sleijfer, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study
    M D Michaelson
    A X Zhu
    D P Ryan
    D F McDermott
    G I Shapiro
    L Tye
    I Chen
    P Stephenson
    S Patyna
    A Ruiz-Garcia
    A B Schwarzberg
    British Journal of Cancer, 2013, 108 : 1393 - 1401
  • [10] Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study
    Michaelson, M. D.
    Zhu, A. X.
    Ryan, D. P.
    McDermott, D. F.
    Shapiro, G. I.
    Tye, L.
    Chen, I.
    Stephenson, P.
    Patyna, S.
    Ruiz-Garcia, A.
    Schwarzberg, A. B.
    BRITISH JOURNAL OF CANCER, 2013, 108 (07) : 1393 - 1401
12345